Circulating calprotectin levels four months after severe and non-severe COVID-19

BMC Infectious Diseases

Table 1 Bern and Lausanne Cohorts´ Baseline Characteristics

	Bern Non-ICU (n = 99)	Bern Post-ICU (n = 25)	Lausanne Post-ICU (n = 68)	p-value
Age, yr.	48.84 ± 13.40	59.35 ± 13.60	60.52 ± 12.02	< 0.0001^a,b
Sex, M (%)	44 (44.4%)	18 (72.0%)	52 (76.5%)	< 0.0001^a,b
BMI, kg/m²	25.24 ± 5.94	28.65 ± 4.55	29.19 ± 5.33	< 0.001^a,b
Lung impairment, (%)	16 (18.4%)	14 (58.3%)	45 (67.2%)	< 0.0001^a,b
DLCO, % pred.	97.79 ± 21.70	75.96 ± 19.05	71.11 ± 18.50	< 0.0001^a,b
FVC, % pred.	97.40 ± 15.42	87.65 ± 14.11	87.11 ± 20.96	< 0.012^a,b
TLC, % pred.	100.98 ± 17.79	86.70 ± 15.07	82.91 ± 18.85	0.001^a,b
Desaturation index, %	3.84 ± 5.19	5.17 ± 3.80	6.86 ± 3.93	< 0.039^a,b

^aBern Non-ICU vs. Bern Post ICU
^bBern Non-ICU vs. Lausanne Post-ICU
^cBern Post-ICU vs. Lausanne Post-ICU
Abbreviation: BMI: Body mass index; DLCO: diffusing capacity for carbon monoxide; FVC: Forced vital capacity; ICU: Intensive care unit; ILD: Interstitial lung disease; TLC: Total lung capacity

ISSN: 1471-2334